Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis.

Literature DB >> 34642767

Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis.

Birgit Sadoghi, Birger Kränke, Lorenzo Cerroni, Wolfgang Weger¹.

Abstract

Entities: Chemical

Mesh：

Substances：
Methotrexate

Year: 2021 PMID： 34642767 PMCID： PMC9455312 DOI： 10.2340/actadv.v101.352

Source DB: PubMed Journal: Acta Derm Venereol ISSN： 0001-5555 Impact factor: 3.875

× No keyword cloud information.

12 in total

1. Injection site reactions to TNF-alpha blocking agents with positive skin tests.

Authors: M Benucci; M Manfredi; P Demoly; P Campi
Journal: Allergy Date: 2008-01 Impact factor: 13.146

Review 2. Fixed drug eruption: state of the art.

Authors: Esen Ozkaya
Journal: J Dtsch Dermatol Ges Date: 2007-12-10 Impact factor: 5.584

3. [S3-guidelines for the treatment of psoriasis vulgaris Update 2011].

Authors: Alexander Nast; Wolf-Henning Boehncke; Ulrich Mrowietz; Hans-Michael Ockenfels; Sandra Philipp; Kristian Reich; Thomas Rosenbach; Adel Sammain; Martin Schlaeger; Michael Sebastian; Wolfram Sterry; Volker Streit; Matthias Augustin; Ricardo Erdmann; Joachim Klaus; Joachim Koza; Siegrid Müller; Hans-Dieter Orzechowski; Stefanie Rosumeck; Gerhard Schmid-Ott; Tobias Weberschock; Berthold Rzany
Journal: J Dtsch Dermatol Ges Date: 2011-06 Impact factor: 5.584

4. Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker.

Authors: Julie Delyon; Nicolas Ortonne; Emmanuel Benayoun; Julien Moroch; Pierre Wolkenstein; Emilie Sbidian; Olivier Chosidow
Journal: J Am Acad Dermatol Date: 2015-07-16 Impact factor: 11.527

5. Safety and Tolerability of Ixekizumab: Integrated Analysis of Injection-Site Reactions from 11 Clinical Trials.

Authors: Neil H Shear; Carle Paul; Andrew Blauvelt; Melinda Gooderham; Craig Leonardi; Kristian Reich; Mamitaro Ohtsuki; Beth Pangallo; Wen Xu; Susan Ball; Terri Ridenour; Hitoe Torisu-Itakura; Noah Agada; Lotus Mallbris
Journal: J Drugs Dermatol Date: 2018-02-01 Impact factor: 2.114

6. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.

Authors: Mallory B Shiver; Lauren A Hall; Kelly B Conner; Grace E Brown; Wang L Cheung; Marla L Wirges
Journal: Dermatol Online J Date: 2014-07-15

Review 7. Psoriasis.

Authors: Wolf-Henning Boehncke; Michael P Schön
Journal: Lancet Date: 2015-05-27 Impact factor: 79.321

Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis.

1. Injection site reactions to TNF-alpha blocking agents with positive skin tests.

Review 2. Fixed drug eruption: state of the art.

3. [S3-guidelines for the treatment of psoriasis vulgaris Update 2011].

4. Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker.

5. Safety and Tolerability of Ixekizumab: Integrated Analysis of Injection-Site Reactions from 11 Clinical Trials.

6. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.

Review 7. Psoriasis.

Review 8. Hypersensitivity reactions to biological drugs.

Review 9. The possibilities and principles of methotrexate treatment of psoriasis - the updated knowledge.

10. Addition of cyclosporine to adalimumab improved psoriasis and adalimumab-induced injection site reaction.

1. Methotrexate injection site reactions: Case report and literature review.